The increasing cost of developing life science products and the financial constrains, create a desperate need for capital efficiency and reduction of risk in clinical development
BBCR offers solutions that reduce risks in clinical trials
There is a growing consensus that traditional cost-cutting and productivity-enhancement methods have largely run their course
BBCR offers capital-efficiency in clinical trials
Start-ups that have had setbacks, like having drugs fail in clinical trials, may no longer get second and third chances to succeed.
BBCR offers solutions that accelerate value-creation in Phase 1 and POC studies
Home
We work with, drug and device, biotech companies to provide innovative clinical development strategies and trial design.
BBCR is a Strategic Clinical Innovation Organization (SCIO) that provides boutique consulting. BBCR’s innovative paradigm includes:
- Design-focused clinical trials that accelerate value-creation in early stage clinical development
- Innovative complex, streamlined, clinical development strategies for a capital-efficient success
- Evidence-based trial design that effectively reduce the clinical trial margins relative risks improving trial success rates
We are committed to our customers and dedicated to innovation. Our team will work seamlessly with our customers making their goals’ achievement our successRead More →
The challenges of our time require a strategic innovation approach to build the drugs and devices of the future.Read More →
Frequently Asked QuestionsRead Our FAQ →
We offer clinical strategy specialist service to biopharmaceutical companies.Read More About Our Services →
Testimonials
"I found BBCR’s group of experts to be knowledgeable, articulate, and friendly, and I would recommend Dr. Fratazzi and the services of BBCR to anyone looking for insightful clinical strategy and practical trial design to be delivered on time with the minimum of fuss." - Joel A. Berniac, PhD, MBA, President & CEO